Natural product-derived phytochemicals as potential agents against coronaviruses: A review

Janice S Mani, Joel B Johnson, Jason C Steel, Daniel A Broszczak, Paul M Neilsen, Kerry B Walsh, Mani Naiker, Janice S Mani, Joel B Johnson, Jason C Steel, Daniel A Broszczak, Paul M Neilsen, Kerry B Walsh, Mani Naiker

Abstract

Coronaviruses are responsible for a growing economic, social and mortality burden, as the causative agent of diseases such as severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), avian infectious bronchitis virus (IBV) and COVID-19. However, there is a lack of effective antiviral agents for many coronavirus strains. Naturally existing compounds provide a wealth of chemical diversity, including antiviral activity, and thus may have utility as therapeutic agents against coronaviral infections. The PubMed database was searched for papers including the keywords coronavirus, SARS or MERS, as well as traditional medicine, herbal, remedy or plants, with 55 primary research articles identified. The overwhelming majority of publications focussed on polar compounds. Compounds that show promise for the inhibition of coronavirus in humans include scutellarein, silvestrol, tryptanthrin, saikosaponin B2, quercetin, myricetin, caffeic acid, psoralidin, isobavachalcone, and lectins such as griffithsin. Other compounds such as lycorine may be suitable if a therapeutic level of antiviral activity can be achieved without exceeding toxic plasma concentrations. It was noted that the most promising small molecules identified as coronavirus inhibitors contained a conjugated fused ring structure with the majority being classified as being polyphenols.

Keywords: COVID-19; Coronaviridae; Middle East respiratory syndrome (MERS); SARS-CoV-2; Severe acute respiratory syndrome (SARS); Traditional medicine.

Conflict of interest statement

Declaration of Competing Interest The authors declare that no conflict of interest exists.

Copyright © 2020 Elsevier B.V. All rights reserved.

Figures

Graphical abstract
Graphical abstract
Fig. 1
Fig. 1
The general structure of a coronavirus (reproduced from Wikipedia under CC licence 4.0). E protein = envelope protein.
Fig. 2
Fig. 2
The structure of selected naturally occurring compounds that demonstrate promising anti-coronavirus activity. (1) Quercetin (2) Quercetin 7-rhamnoside (3) Myricetin (4) Psoralidin (5) Caffeic acid (6) Tryptanthrin (7) Lycorine (8) Scutellarein (9) Silvestrol (10) Saikosaponin B2 (11) Isobavachalcone (12) Griffithsin. As annotated on (4), note the aromatic rings and substituted fused rings present in most compounds.
Fig. 3
Fig. 3
Possible binding sites of quercetin in SARS-CoV-2 3CLpro and tryptanthrin in PLpro. Docking was performed in AutoDock Vina 1.1.2 (Trott and Olson, 2010) against target proteins generated by SWISS-MODEL (https://swissmodel.expasy.org/repository/species/2697049).

References

    1. Aldeghi M., Heifetz A., Bodkin M.J., Knapp S., Biggin P.C. Accurate calculation of the absolute free energy of binding for drug molecules. Chem. Sci. 2016;7(1):207–218.
    1. Cassidy L., Fernandez F., Johnson J.B., Naiker M., Owoola A.G., Broszczak D.A. Oxidative stress in alzheimer’s disease: a review on emergent natural polyphenolic therapeutics. Complement. Ther. Med. 2019:102294. doi: 10.1016/j.ctim.2019.102294.
    1. Chen C.J., Michaelis M., Hsu H.K., Tsai C.C., Yang K.D., Wu Y.C., Cinatl J., Jr., Doerr H.W. Toona sinensis Roem tender leaf extract inhibits SARS coronavirus replication. J. Ethnopharmacol. 2008;120(1):108–111.
    1. Chen C., Zuckerman D.M., Brantley S., Sharpe M., Childress K., Hoiczyk E., Pendleton A.R. Sambucus nigra extracts inhibit infectious bronchitis virus at an early point during replication. BMC Vet. Res. 2014;10:24.
    1. Chen Y., de Bruyn Kops C., Kirchmair J. Data resources for the computer-guided discovery of bioactive natural products. J. Chem. Inf. Model. 2017;57(9):2099–2111.
    1. Cheng P.W., Ng L.T., Chiang L.C., Lin C.C. Antiviral effects of saikosaponins on human coronavirus 229E in vitro. Clin. Exp. Pharmacol. Physiol. 2006;33(7):612–616.
    1. Chiang L.-C., Ng L.T., Liu L.-T., Shieh D.-e., Lin C.-C. Cytotoxicity and anti-hepatitis B virus activities of saikosaponins from Bupleurum species. Planta Med. 2003;69(8):705–709.
    1. Cho J.K., Curtis-Long M.J., Lee K.H., Kim D.W., Ryu H.W., Yuk H.J., Park K.H. Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia tomentosa. Bioorg. Med. Chem. 2013;21(11):3051–3057.
    1. Choi H.-J., Kim J.-H., Lee C.-H., Ahn Y.-J., Song J.-H., Baek S.-H., Kwon D.-H. Antiviral activity of quercetin 7-rhamnoside against porcine epidemic diarrhea virus. Antiviral Research. 2009;81(1):77–81.
    1. Chu D.K., Pan Y., Cheng S., Hui K.P., Krishnan P., Liu Y., Ng D.Y., Wan C.K., Yang P., Wang Q. Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia. Clin. Chem. 2020;66(4):549–555.
    1. . U.S. National Library of Medicine; 2020. COVID-19 - List Results.
    1. Cortegiani A., Ingoglia G., Ippolito M., Giarratano A., Einav S. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J. Crit. Care. 2020 doi: 10.1016/j.jcrc.2020.03.005.
    1. Covés-Datson E.M., Dyall J., DeWald L.E., King S.R., Dube D., Legendre M., Nelson E., Drews K.C., Gross R., Gerhardt D.M. Inhibition of Ebola virus by a molecularly engineered banana lectin. PLoS Negl. Trop. Dis. 2019;13(7)
    1. Forli S., Huey R., Pique M.E., Sanner M.F., Goodsell D.S., Olson A.J. Computational protein–ligand docking and virtual drug screening with the AutoDock suite. Nat. Protoc. 2016;11(5):905.
    1. Ganjhu R.K., Mudgal P.P., Maity H., Dowarha D., Devadiga S., Nag S., Arunkumar G. Herbal plants and plant preparations as remedial approach for viral diseases. VirusDisease. 2015;26(4):225–236.
    1. Gao J., Tian Z., Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci. Trends. 2020;14(1):72–73.
    1. Haiying L., Na H., Xiaoyuan X. The curative effects of glycyrrhizin on patients with SARS. Annual Meeting of The Society of Infectious and Parasitic Diseases; Chinese Medical Association, Wuhan, China; 2003. pp. 18–22.
    1. Häkkinen S.H., Kärenlampi S.O., Heinonen I.M., Mykkänen H.M., Törrönen A.R. Content of the flavonols quercetin, myricetin, and kaempferol in 25 edible berries. J. Agric. Food Chem. 1999;47(6):2274–2279.
    1. Han T., Li H.-L., Zhang Q.-Y., Han P., Zheng H.-C., Rahman K., Qin L.-P. Bioactivity-guided fractionation for anti-inflammatory and analgesic properties and constituents of Xanthium strumarium L. Phytomedicine. 2007;14(12):825–829.
    1. Ho T.Y., Wu S.L., Chen J.C., Li C.C., Hsiang C.Y. Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction. Antiviral Res. 2007;74(2):92–101.
    1. Hoever G., Baltina L., Michaelis M., Kondratenko R., Baltina L., Tolstikov G.A., Doerr H.W., Cinatl J., Jr. Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus. J. Med. Chem. 2005;48(4):1256–1259.
    1. Holshue M.L., DeBolt C., Lindquist S., Lofy K.H., Wiesman J., Bruce H., Spitters C., Ericson K., Wilkerson S., Tural A. First case of 2019 novel coronavirus in the United States. N. Engl. J. Med. 2020;382:929–936.
    1. Hsieh L.E., Lin C.N., Su B.L., Jan T.R., Chen C.M., Wang C.H., Lin D.S., Lin C.T., Chueh L.L. Synergistic antiviral effect of Galanthus nivalis agglutinin and nelfinavir against feline coronavirus. Antiviral Res. 2010;88(1):25–30.
    1. Huang I.C., Bosch B.J., Li F., Li W., Lee K.H., Ghiran S., Vasilieva N., Dermody T.S., Harrison S.C., Dormitzer P.R., Farzan M. SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells. J. Biol. Chem. 2006;281(6):3198–3203.
    1. Hui D.S., I Azhar E., Madani T.A., Ntoumi F., Kock R., Dar O., Ippolito G., McHugh T.D., Memish Z.A., Drosten C., Zumla A., Petersen E. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — the latest 2019 novel coronavirus outbreak in Wuhan, China. Int. J. Infect. Dis. 2020;91:264–266.
    1. Hwang H.-J., Han J.-W., Jeon H., Cho K., Kim J.-h., Lee D.-S., Han J.W. Characterization of a novel mannose-binding lectin with antiviral activities from red alga, Grateloupia chiangii. Biomolecules. 2020;10(2):333.
    1. Jackwood M.W., Rosenbloom R., Petteruti M., Hilt D.A., McCall A.W., Williams S.M. Avian coronavirus infectious bronchitis virus susceptibility to botanical oleoresins and essential oils in vitro and in vivo. Virus Res. 2010;149(1):86–94.
    1. Justesen U., Knuthsen P. Composition of flavonoids in fresh herbs and calculation of flavonoid intake by use of herbs in traditional Danish dishes. Food Chem. 2001;73(2):245–250.
    1. Kaack K., Austed T. Interaction of vitamin C and flavonoids in elderberry (Sambucus nigra L.) during juice processing. Plant Foods Hum. Nutr. 1998;52(3):187–198.
    1. Kang K.B., Ming G., Kim G.J., Ha T.K., Choi H., Oh W.K., Sung S.H. Jubanines F-J, cyclopeptide alkaloids from the roots of Ziziphus jujuba. Phytochemistry. 2015;119:90–95.
    1. Kaur R., Manjal S.K., Rawal R.K., Kumar K. Recent synthetic and medicinal perspectives of tryptanthrin. Bioorg. Med. Chem. 2017;25(17):4533–4552.
    1. Keyaerts E., Vijgen L., Pannecouque C., Van Damme E., Peumans W., Egberink H., Balzarini J., Van Ranst M. Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle. Antiviral Res. 2007;75(3):179–187.
    1. Khamitov R., Loginova S., Shchukina V., Borisevich S., Maksimov V., Shuster A. Antiviral activity of arbidol and its derivatives against the pathogen of severe acute respiratory syndrome in the cell cultures. Vopr. Virusol. 2008;53(4):9–13.
    1. Khan H., Sureda A., Belwal T., Çetinkaya S., Süntar İ., Tejada S., Devkota H.P., Ullah H., Aschner M. Polyphenols in the treatment of autoimmune diseases. Autoimmun. Rev. 2019;18(7):647–657.
    1. Kim H.Y., Shin H.S., Park H., Kim Y.C., Yun Y.G., Park S., Shin H.J., Kim K. In vitro inhibition of coronavirus replications by the traditionally used medicinal herbal extracts, Cimicifuga rhizoma, Meliae cortex, Coptidis rhizoma, and Phellodendron cortex. J. Clin. Virol. 2008;41(2):122–128.
    1. Kim H.Y., Eo E.Y., Park H., Kim Y.C., Park S., Shin H.J., Kim K. Medicinal herbal extracts of Sophorae radix, Acanthopanacis cortex, Sanguisorbae radix and Torilis fructus inhibit coronavirus replication in vitro. Antivir. Ther. (Lond.) 2010;15(5):697–709.
    1. Kim D.W., Seo K.H., Curtis-Long M.J., Oh K.Y., Oh J.W., Cho J.K., Lee K.H., Park K.H. Phenolic phytochemical displaying SARS-CoV papain-like protease inhibition from the seeds of Psoralea corylifolia. J. Enzyme Inhib. Med. Chem. 2014;29(1):59–63.
    1. Kim D.E., Min J.S., Jang M.S., Lee J.Y., Shin Y.S., Song J.H., Kim H.R., Kim S., Jin Y.H., Kwon S. Natural Bis-Benzylisoquinoline Alkaloids-Tetrandrine, Fangchinoline, and Cepharanthine, inhibit human coronavirus OC43 infection of MRC-5 human lung cells. Biomolecules. 2019;9(11):696.
    1. Kretzing S., Abraham G., Seiwert B., Ungemach F.R., Krügel U., Regenthal R. Dose-dependent emetic effects of the Amaryllidaceous alkaloid lycorine in beagle dogs. Toxicon. 2011;57(1):117–124.
    1. Kumaki Y., Wandersee M.K., Smith A.J., Zhou Y., Simmons G., Nelson N.M., Bailey K.W., Vest Z.G., Li J.K., Chan P.K., Smee D.F., Barnard D.L. Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin. Antiviral Res. 2011;90(1):22–32.
    1. Lau K.M., Lee K.M., Koon C.M., Cheung C.S., Lau C.P., Ho H.M., Lee M.Y., Au S.W., Cheng C.H., Lau C.B., Tsui S.K., Wan D.C., Waye M.M., Wong K.B., Wong C.K., Lam C.W., Leung P.C., Fung K.P. Immunomodulatory and anti-SARS activities of Houttuynia cordata. J. Ethnopharmacol. 2008;118(1):79–85.
    1. Lee J.H., Park J.S., Lee S.W., Hwang S.Y., Young B.E., Choi H.J. Porcine epidemic diarrhea virus infection: inhibition by polysaccharide from Ginkgo biloba exocarp and mode of its action. Virus Res. 2015;195:148–152.
    1. Lelesius R., Karpovaite A., Mickiene R., Drevinskas T., Tiso N., Ragazinskiene O., Kubiliene L., Maruska A., Salomskas A. In vitro antiviral activity of fifteen plant extracts against avian infectious bronchitis virus. BMC Vet. Res. 2019;15(1):178.
    1. Letko M., Marzi A., Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat. Microbiol. 2020;5(4):562–569.
    1. Li S.Y., Chen C., Zhang H.Q., Guo H.Y., Wang H., Wang L., Zhang X., Hua S.N., Yu J., Xiao P.G., Li R.S., Tan X. Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res. 2005;67(1):18–23.
    1. Li H., Wu J., Zhang Z., Ma Y., Liao F., Zhang Y., Wu G. Forsythoside a inhibits the avian infectious bronchitis virus in cell culture. Phytother. Res. 2011;25(3):338–342.
    1. Li L., Yu X., Zhang H., Cheng H., Hou L., Zheng Q., Hou J. In vitro antiviral activity of Griffithsin against porcine epidemic diarrhea virus. Virus Genes. 2019;55(2):174–181.
    1. Lin C.W., Tsai F.J., Tsai C.H., Lai C.C., Wan L., Ho T.Y., Hsieh C.C., Chao P.D. Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. Antiviral Res. 2005;68(1):36–42.
    1. Lin L.-T., Hsu W.-C., Lin C.-C. Antiviral natural products and herbal medicines. J. Tradit. Complement. Med. 2014;4(1):24–35.
    1. Lin L.-T., Chung C.-Y., Hsu W.-C., Chang S.-P., Hung T.-C., Shields J., Russell R.S., Lin C.-C., Li C.-F., Yen M.-H. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry. J. Hepatol. 2015;62(3):541–548.
    1. Ling C.-q. Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2) J. Integr. Med. 2020;18(2):87–88.
    1. Liu B., Zhou J. SARS-CoV protease inhibitors design using virtual screening method from natural products libraries. J. Comput. Chem. 2005;26(5):484–490.
    1. Loizzo M.R., Saab A.M., Tundis R., Statti G.A., Menichini F., Lampronti I., Gambari R., Cinatl J., Doerr H.W. Phytochemical analysis and in vitro antiviral activities of the essential oils of seven Lebanon species. Chem. Biodivers. 2008;5(3):461–470.
    1. Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV) Biosci. Trends. 2020;14(1):69–71.
    1. Lu G., Wang Q., Gao G.F. Bat-to-human: spike features determining ‘host jump’of coronaviruses SARS-CoV, MERS-CoV, and beyond. Trends Microbiol. 2015;23(8):468–478.
    1. Lung J., Lin Y.S., Yang Y.H., Chou Y.L., Shu L.H., Cheng Y.C., Liu H.T., Wu C.Y. The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase. J. Med. Virol. 2020;92(6):693–697.
    1. Luo W., Su X., Gong S., Qin Y., Liu W., Li J., Yu H., Xu Q. Anti-SARS coronavirus 3C-like protease effects ofRheum palmatum L. extracts. Biosci. Trends. 2009;3(4):124–126.
    1. Luo H., Tang Q.-l., Shang Y.-x., Liang S.-b., Yang M., Robinson N., Liu J.-p. Can Chinese medicine be used for prevention of corona virus disease 2019 (COVID-19)? A review of historical classics, research evidence and current prevention programs. Chin. J. Integr. Med. 2020;26(4):243–250.
    1. McCutcheon A.R., Roberts T.E., Gibbons E., Ellis S.M., Babiuk L.A., Hancock R.E., Towers G.H. Antiviral screening of British Columbian medicinal plants. J. Ethnopharmacol. 1995;49(2):101–110.
    1. McDonagh P., Sheehy P.A., Norris J.M. Identification and characterisation of small molecule inhibitors of feline coronavirus replication. Vet. Microbiol. 2014;174(3–4):438–447.
    1. Michaelis M., Doerr H.W., Cinatl J., Jr. Investigation of the influence of EPs(R) 7630, a herbal drug preparation from Pelargonium sidoides, on replication of a broad panel of respiratory viruses. Phytomedicine. 2011;18(5):384–386.
    1. Michelow I.C., Lear C., Scully C., Prugar L.I., Longley C.B., Yantosca L.M., Ji X., Karpel M., Brudner M., Takahashi K. High-dose mannose-binding lectin therapy for Ebola virus infection. J. Infect. Dis. 2011;203(2):175–179.
    1. Miean K.H., Mohamed S. Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants. J. Agric. Food Chem. 2001;49(6):3106–3112.
    1. Millet J.K., Seron K., Labitt R.N., Danneels A., Palmer K.E., Whittaker G.R., Dubuisson J., Belouzard S. Middle East respiratory syndrome coronavirus infection is inhibited by griffithsin. Antiviral Res. 2016;133:1–8.
    1. Mitchell C.A., Ramessar K., O’Keefe B.R. Antiviral lectins: selective inhibitors of viral entry. Antiviral Res. 2017;142:37–54.
    1. Müller C., Schulte F.W., Lange-Grunweller K., Obermann W., Madhugiri R., Pleschka S., Ziebuhr J., Hartmann R.K., Grunweller A. Broad-spectrum antiviral activity of the eIF4A inhibitor silvestrol against corona- and picornaviruses. Antiviral Res. 2018;150:123–129.
    1. Müller C., Obermann W., Schulte F.W., Lange-Grünweller K., Oestereich L., Elgner F., Glitscher M., Hildt E., Singh K., Hans-Guido W., Hartmann R.K. Comparison of broad-spectrum antiviral activities of the synthetic rocaglate CR-31-B (−) and the eIF4A-inhibitor silvestrol. Antiviral Res. 2020;175
    1. Newman D.J., Cragg G.M. Natural products as sources of new drugs from 1981 to 2014. J. Nat. Prod. 2016;79(3):629–661.
    1. Nguyen P.Q., Ooi J.S., Nguyen N.T., Wang S., Huang M., Liu D.X., Tam J.P. Antiviral cystine knot alpha-amylase inhibitors from Alstonia scholaris. J. Biol. Chem. 2015;290(52):31138–31150.
    1. O’Keefe B.R., Giomarelli B., Barnard D.L., Shenoy S.R., Chan P.K., McMahon J.B., Palmer K.E., Barnett B.W., Meyerholz D.K., Wohlford-Lenane C.L., McCray P.B., Jr. Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family Coronaviridae. J. Virol. 2010;84(5):2511–2521.
    1. Pang J., Wang M.X., Ang I.Y.H., Tan S.H.X., Lewis R.F., Chen J.I.-P., Gutierrez R.A., Gwee S.X.W., Chua P.E.Y., Yang Q. Potential rapid diagnostics, vaccine and therapeutics for 2019 novel Coronavirus (2019-ncoV): a systematic review. J. Clin. Med. 2020;9(3):623.
    1. Paraskevis D., Kostaki E.G., Magiorkinis G., Panayiotakopoulos G., Sourvinos G., Tsiodras S. Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infect. Genet. Evol. 2020;79
    1. Park J.Y., Kim J.H., Kim Y.M., Jeong H.J., Kim D.W., Park K.H., Kwon H.J., Park S.J., Lee W.S., Ryu Y.B. Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases. Bioorg. Med. Chem. 2012;20(19):5928–5935.
    1. Park J.Y., Yuk H.J., Ryu H.W., Lim S.H., Kim K.S., Park K.H., Ryu Y.B., Lee W.S. Evaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors. J. Enzyme Inhib. Med. Chem. 2017;32(1):504–515.
    1. Pawlotsky J.-M. New hepatitis C virus (HCV) drugs and the hope for a cure: concepts in anti-HCV drug development. Semin. Liver Dis. 2014;34:022–029.
    1. Petersen K.A., Matthiesen F., Agger T., Kongerslev L., Thiel S., Cornelissen K., Axelsen M. Phase I safety, tolerability, and pharmacokinetic study of recombinant human mannan-binding lectin. J. Clin. Immunol. 2006;26(5):465–475.
    1. Runfeng L., Yunlong H., Jicheng H., Weiqi P., Qinhai M., Yongxia S., Chufang L., Jin Z., Zhenhua J., Haiming J., Kui Z., Shuxiang H., Jun D., Xiaobo L., Xiaotao H., Lin W., Nanshan Z., Zifeng Y. Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2) Pharmacol. Res. 2020;156
    1. Ryu Y.B., Jeong H.J., Kim J.H., Kim Y.M., Park J.-Y., Kim D., Naguyen T.T.H., Park S.-J., Chang J.S., Park K.H. Biflavonoids from Torreya nucifera displaying SARS-CoV 3CLpro inhibition. Bioorg. Med. Chem. 2010;18(22):7940–7947.
    1. Ryu Y.B., Park S.J., Kim Y.M., Lee J.Y., Seo W.D., Chang J.S., Park K.H., Rho M.C., Lee W.S. SARS-CoV 3CLpro inhibitory effects of quinone-methide triterpenes from Tripterygium regelii. Bioorg. Med. Chem. Lett. 2010;20(6):1873–1876.
    1. Schoeman D., Fielding B.C. Coronavirus envelope protein: current knowledge. Virol. J. 2019;16(1):69.
    1. Shen Y.C., Wang L.T., Khalil A.T., Chiang L.C., Cheng P.W. Bioactive pyranoxanthones from the roots of Calophyllum blancoi. Chem Pharm Bull (Tokyo). 2005;53(2):244–247.
    1. Simmons G., Gosalia D.N., Rennekamp A.J., Reeves J.D., Diamond S.L., Bates P. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc. Natl. Acad. Sci. 2005;102(33):11876–11881.
    1. Sohrabi C., Alsafi Z., O’Neill N., Khan M., Kerwan A., Al-Jabir A., Iosifidis C., Agha R. World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19) Int. J. Surg. 2020;76:71–76.
    1. Song J.H., Shim J.K., Choi H.J. Quercetin 7-rhamnoside reduces porcine epidemic diarrhea virus replication via independent pathway of viral induced reactive oxygen species. Virol. J. 2011;8:460.
    1. Sudhan A.R., Siemann D.W. Cathepsin L targeting in cancer treatment. Pharmacol. Ther. 2015;155:105–116.
    1. Sundararajan A., Ganapathy R., Huan L., Dunlap J.R., Webby R.J., Kotwal G.J., Sangster M.Y. Influenza virus variation in susceptibility to inactivation by pomegranate polyphenols is determined by envelope glycoproteins. Antiviral Res. 2010;88(1):1–9.
    1. Theerawatanasirikul S., Kuo C.J., Phetcharat N., Lekcharoensuk P. In silico and in vitro analysis of small molecules and natural compounds targeting the 3CL protease of feline infectious peritonitis virus. Antiviral Res. 2020;174
    1. Tian F., Li B., Ji B., Yang J., Zhang G., Chen Y., Luo Y. Antioxidant and antimicrobial activities of consecutive extracts from Galla chinensis:the polarity affects the bioactivities. Food Chem. 2009;113(1):173–179.
    1. Tome-Carneiro J., Visioli F. Polyphenol-based nutraceuticals for the prevention and treatment of cardiovascular disease: review of human evidence. Phytomedicine. 2016;23(11):1145–1174.
    1. Toney J.H., Navas-Martin S., Weiss S.R., Koeller A. Sabadinine: a potential non-peptide anti-severe acute-respiratory-syndrome agent identified using structure-aided design. J. Med. Chem. 2004;47(5):1079–1080.
    1. Tsai Y.C., Lee C.L., Yen H.R., Chang Y.S., Lin Y.P., Huang S.H., Lin C.W. Antiviral action of tryptanthrin isolated from Strobilanthes cusia leaf against human coronavirus NL63. Biomolecules. 2020;10(3)
    1. Ulasli M., Gurses S.A., Bayraktar R., Yumrutas O., Oztuzcu S., Igci M., Igci Y.Z., Cakmak E.A., Arslan A. The effects of Nigella sativa (Ns), Anthemis hyalina (Ah) and Citrus sinensis (Cs) extracts on the replication of coronavirus and the expression of TRP genes family. Mol. Biol. Rep. 2014;41(3):1703–1711.
    1. Ushio Y., Abe H. Inactivation of measles virus and herpes simplex virus by saikosaponin d. Planta Med. 1992;58(2):171–173.
    1. Wan S., Xiang Y., Fang W., Zheng Y., Li B., Hu Y., Lang C., Huang D., Sun Q., Xiong Y., Huang X., Lv J., Luo Y., Shen L., Yang H., Huang G., Yang R. Clinical features and treatment of COVID-19 patients in Northeast Chongqing. J. Med. Virol. 2020 doi: 10.1002/jmv.25783.
    1. Wang Z.M., Zhu X.X., Cui X.L., Liang A.H., Du G.H., Ruan J.X., Sun J.N., Li P.T., Wang S.R. Screening of traditional Chinese remedies for SARS treatment. Zhongguo Zhong Yao Za Zhi. 2003;28(6):484–487.
    1. Wang S.Q., Du Q.S., Zhao K., Li A.X., Wei D.Q., Chou K.C. Virtual screening for finding natural inhibitor against cathepsin-L for SARS therapy. Amino Acids. 2007;33(1):129–135.
    1. Wang G.-F., Shi L.-P., Ren Y.-D., Liu Q.-F., Liu H.-F., Zhang R.-J., Li Z., Zhu F.-H., He P.-L., Tang W. Anti-hepatitis B virus activity of chlorogenic acid, quinic acid and caffeic acid in vivo and in vitro. Antiviral Res. 2009;83(2):186–190.
    1. Wang M., Cao R., Zhang L., Yang X., Liu J., Xu M., Shi Z., Hu Z., Zhong W., Xiao G. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269–271.
    1. Wen C.C., Shyur L.F., Jan J.T., Liang P.H., Kuo C.J., Arulselvan P., Wu J.B., Kuo S.C., Yang N.S. Traditional Chinese medicine herbal extracts of Cibotium barometz, Gentiana scabra, Dioscorea batatas, Cassia tora, and Taxillus chinensis inhibit SARS-CoV replication. J. Tradit. Complement. Med. 2011;1(1):41–50.
    1. Weng J.R., Lin C.S., Lai H.C., Lin Y.P., Wang C.Y., Tsai Y.C., Wu K.C., Huang S.H., Lin C.W. Antiviral activity of Sambucus formosana Nakai ethanol extract and related phenolic acid constituents against human coronavirus NL63. Virus Res. 2019;273
    1. Wigmore S.M., Naiker M., Bean D.C. Antimicrobial activity of extracts from native plants of temperate Australia. Pharmacogn. Commun. 2016;6(2):80–84.
    1. Wittemer S.M., Ploch M., Windeck T., Müller S.C., Drewelow B., Derendorf H., Veit M. Bioavailability and pharmacokinetics of caffeoylquinic acids and flavonoids after oral administration of Artichoke leaf extracts in humans. Phytomedicine. 2005;12(1):28–38.
    1. World Health Organization . World Health Organization; 2019. WHO MERS Global Summary and Assessment of Risk, July 2019.
    1. Wu A., Peng Y., Huang B., Ding X., Wang X., Niu P., Meng J., Zhu Z., Zhang Z., Wang J., Sheng J. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe. 2020;27(3):325–328.
    1. Wu C., Liu Y., Yang Y., Zhang P., Zhong W., Wang Y., Wang Q., Xu Y., Li M., Li X., Zheng M., Chen L., Li H. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm. Sin. B. 2020 doi: 10.1016/j.apsb.2020.02.008.
    1. Yang Q.Y., Tian X.Y., Fang W.S. Bioactive coumarins from Boenninghausenia sessilicarpa. J. Asian Nat. Prod. Res. 2007;9(1):59–65.
    1. Yang Z., Wu N., Fu Y., Yang G., Wang W., Zu Y., Efferth T. Anti-infectious bronchitis virus (IBV) activity of 1,8-cineole: effect on nucleocapsid (N) protein. J. Biomol. Struct. Dyn. 2010;28(3):323–330.
    1. Yang Z., Wu N., Zu Y., Fu Y. Comparative anti-infectious bronchitis virus (IBV) activity of (-)-pinene: effect on nucleocapsid (N) protein. Molecules. 2011;16(2):1044–1054.
    1. Yang Y., Islam M.S., Wang J., Li Y., Chen X. Traditional chinese medicine in the treatment of patients infected with 2019-New coronavirus (SARS-CoV-2): a review and perspective. Int. J. Biol. Sci. 2020;16(10):1708–1717.
    1. Yang Y., Peng F., Wang R., Guan K., Jiang T., Xu G., Sun J., Chang C. The deadly coronaviruses: the 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. J. Autoimmun. 2020;109
    1. Yao T.T., Qian J.D., Zhu W.Y., Wang Y., Wang G.Q. A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus–A possible reference for coronavirus Disease‐19 treatment option. J. Med. Virol. 2020;92(6):556–563.
    1. Yi L., Li Z., Yuan K., Qu X., Chen J., Wang G., Zhang H., Luo H., Zhu L., Jiang P., Chen L., Shen Y., Luo M., Zuo G., Hu J., Duan D., Nie Y., Shi X., Wang W., Han Y., Li T., Liu Y., Ding M., Deng H., Xu X. Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells. J. Virol. 2004;78(20):11334–11339.
    1. Yin J., Li G., Li J., Yang Q., Ren X. In vitro and in vivo effects of Houttuynia cordata on infectious bronchitis virus. Avian Pathol. 2011;40(5):491–498.
    1. Yook H.S., Kim K.H., Park J.E., Shin H.J. Antioxidative and antiviral properties of flowering cherry fruits (Prunus serrulata L. Var. spontanea). Am J Chin Med. 2010;38(5):937–948.
    1. Yu M.-S., Lee J., Lee J.M., Kim Y., Chin Y.-W., Jee J.-G., Keum Y.-S., Jeong Y.-J. Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13. Bioorg. Med. Chem. Lett. 2012;22(12):4049–4054.
    1. Zhang D.H., Wu K.L., Zhang X., Deng S.Q., Peng B. In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. J. Integr. Med. 2020;18(2):152–158.
    1. Zhao Q., Chen X.-Y., Martin C. Scutellaria baicalensis, the golden herb from the garden of Chinese medicinal plants. Sci. Bull. (Beijing) 2016;61(18):1391–1398.
    1. Zhao Y., Feng L., Liu L., Zhao R. Saikosaponin b2 enhances the hepatotargeting effect of anticancer drugs through inhibition of multidrug resistance-associated drug transporters. Life Sci. 2019;231
    1. Zhuang M., Jiang H., Suzuki Y., Li X., Xiao P., Tanaka T., Ling H., Yang B., Saitoh H., Zhang L., Qin C., Sugamura K., Hattori T. Procyanidins and butanol extract of Cinnamomi Cortex inhibit SARS-CoV infection. Antiviral Res. 2009;82(1):73–81.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi